Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
JHEP Reports : Innovation in Hepatology|July 18, 2024
Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosisYou Deng, Haiyan Kang, Huiling Xiang, et al.Journal of Clinical Gastroenterology|June 19, 2018
Real-World Study on Sofosbuvir-based Therapies in Asian Americans With Chronic Hepatitis CCalvin Q Pan, Benjamin C Tiongson, Ke-Qin Hu, et al.Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.BMC Medicine|July 13, 2021
The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort studyXiaohui Zhang, Huaibin Zou, Yu Chen, et al.Plos One|May 13, 2021
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBVCalvin Q Pan, Ting-Tsung Chang, Si Hyun Bae, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2021
Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimensCalvin Q Pan, Ming-Hui Li, Wei Yi, et al.Scandinavian Journal of Gastroenterology|December 6, 2023
The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis BMin-Ran Li, Jin-Zhong Li, De-Hua Wang, et al.Journal of Hepatology|May 24, 2016
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis BAnna S Lok, Calvin Q Pan, Steven-Huy B Han, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 24, 2018
Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir TherapyWei-Hua Cao, Ming-Hui Li, Calvin Q Pan, et al.Alimentary Pharmacology & Therapeutics|August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of TreatmentGrace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.Pageof 11